Skip to main content

ATOSSA THERAPEUTICS, INC.

For the period ended Mar 30, 2026. Filed Mar 30, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Mar 30, 2026 · Filed Mar 30, 2026

Use the contents to explore the available documents and sections.

ATOS$2.12+5.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Effectiveness of Amendment

If approved by stockholders and implemented by the Board, the Reverse Stock Split will become effective upon the filing of the Certificate of Amendment with the Secretary of State of the State of Delaware, or such later date as is chosen by the Board and set forth in the Certificate of Amendment (the “Effective Date”). We will publicly announce the Reverse Stock Split ratio chosen by the Board prior to the Effective Date. The effectiveness of this amendment or the abandonment thereof, notwithstanding stockholder approval, will be determined by the Board, at its sole option, at any time within the one year period following stockholder approval at the Annual Meeting. The text of the proposed form of Certificate of Amendment to our Certificate of Incorporation (the “Certificate of Amendment”) is attached hereto as Appendix A.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.